FDA Says Teleflex, And Arrow International, Recall Pressure Injectable Catheter Kits For Mislabeling; FDA Has Identified Recall Of Pressure Injectable Catheter Kits For Mislabeling As Class I Recall
Portfolio Pulse from Benzinga Newsdesk
The FDA has identified a Class I recall of pressure injectable catheter kits due to mislabeling. The recall involves products from Teleflex and Arrow International.
November 06, 2023 | 9:24 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Teleflex is involved in a Class I recall of pressure injectable catheter kits due to mislabeling, as identified by the FDA.
The FDA's identification of a Class I recall is the most serious type of recall, which can potentially cause serious health problems or death. This could negatively impact Teleflex's reputation and financial performance in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100